🔬 INNBC Research Receives Second Major Citation from Frontiers in Blockchain
🔬 INNBC Research Receives Second Major Citation from Frontiers in Blockchain
📚 Second major citation
A Springer Nature publication on blockchain-based biomedical data storage has received its second significant academic citation. Following an earlier reference from Harvard University, the research is now cited in a new study titled "BirthChain: a blockchain platform for birth certificates" published in Frontiers in Blockchain.
The citation positions the work as a technical reference for implementing decentralized science (DeSci) solutions on BNB Smart Chain and other EVM-compatible networks including Ethereum and Polygon.
Key points:
- Research cited by institutions including Harvard and University College London
- Study serves as practical reference for blockchain engineering applications
- Published in peer-reviewed journals with established academic standards
- Focuses on permanent data storage using blockchain technology
The citations demonstrate growing academic interest in blockchain applications for data management and infrastructure development across multiple networks.
Honored to announce that our @SpringerNature publication (link.springer.com/article/10.118…) has received its second major international citation! 📄✨ Following Harvard, the recent "BirthChain: a blockchain platform for birth certificates" study in @FrontiersIn Blockchain now references
INNBC Expands Beyond Gaming with DeFi Aggregator and Layer-1 Blockchain
Following 14,000+ activations of INNBC STARFIGHTER on Steam, the project is launching three new infrastructure products: - **INNBCswap**: A DeFi aggregator designed to compete with established platforms like 1inch and Kyber Network, using proprietary routing technology across major chains - **INNBC L1 Chain**: An EVM-compatible Layer-1 blockchain focused on decentralized science (DeSci) and gaming, claiming 65,000 transactions per second with $INNBC as the native gas token - **INNBC Wallet**: A multi-chain wallet with native support for the INNBC Chain and major blockchains The project positions itself as product-focused rather than speculative, building on its 2018 DeSci token origins. The Steam game serves as an entry point to introduce blockchain concepts to mainstream gamers. [INNBC STARFIGHTER on Steam](https://store.steampowered.com/app/3977960/INNBC_STARFIGHTER/)
JavaScript Game Engine Powers Commercial Steam Release, Now Open-Sourced
Innovative Bioresearch has released the INNBC STARFIGHTER Engine on GitHub, demonstrating that JavaScript can power commercial-grade games. **Key Features:** - Built with JavaScript and Electron - Delivers 60+ FPS arcade gameplay - Full Steam API integration including achievements - Online multiplayer and lobby support - Gamepad compatibility - Performance-optimized asset caching The engine powers their Steam-released shoot 'em up game and represents a working example of JavaScript technology in commercial gaming. The code is source-available under a commercial license for developers and studios. [View on GitHub](https://github.com/InnovativeBioresearch/INNBC-STARFIGHTER)
INNBC Starfighter Featured by Gaming Press as Top Free Steam Title
**Gaming Press Recognition** INNBC STARFIGHTER received coverage from Spaziogames, being featured as one of the top free-to-play titles on Steam during the Easter holiday period. **Game Details** - 90s-inspired arcade shooter with modern high-resolution graphics - Supports 60+ FPS gameplay - Single-player campaign and online co-op for 2 players - Free-to-play model - Currently available on Steam **DeSci Integration** The game represents an attempt to bridge decentralized science (DeSci) concepts with mainstream gaming. The project aims to provide utility beyond token speculation through actual gaming products. Full coverage: [Spaziogames article](https://www.spaziogames.it/notizie/8-piccoli-giochi-gratis-su-steam-per-festeggiare-la-pasqua)
BPC-157 Peptide Study Protocol Submitted for Preclinical Safety Testing
A **2-month mouse study protocol** for peptide BPC-157 has been officially submitted to the lab for preclinical testing. **Key Study Parameters:** - High-dose chronic safety testing (200 ug/kg) - Functional performance measurements (grip strength, cytokines) - Duration: 2 months **Regulatory Significance:** This dataset will address **critical non-toxicity requirements** from regulatory agencies including AIFA and EMA, which are necessary prerequisites for advancing to human Phase I clinical trials. **Previous Results:** Earlier C. elegans experiments showed a **5.1% increase in lifespan** - marking the first time BPC-157 was tested on this model organism. The study represents a crucial step in building the regulatory bridge toward official approval for human trials of this regenerative medicine peptide.